Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma

Published:2022-11-08 Issue:2 Volume:98 Page:251-263
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Yang Peiyu¹²,Chen Haimin³^ORCID,Liang Xinyue¹,Xu Weiling⁴,Yu Shanshan¹,Huang Wenyang⁵,Yi Xingcheng²,Guo Qiang¹,Tian Mengru¹²,Yue Tingting¹²,Li Mengyao¹⁶,Zhang Yingjie¹,Zhang Mengxue¹,Yan Yurong¹,Hu Zhongli¹,Kumar Shaji K.⁷^ORCID,Zhou Fan³,Dai Yun²^ORCID,Jin Fengyan¹^ORCID

Affiliation:

1. Hematology Department First Hospital of Jilin University Changchun Jilin China

2. Laboratory of Cancer Precision Medicine First Hospital of Jilin University Changchun Jilin China

3. Department of Hematology and Oncology Shanghai Jing'an District Zhabei Central Hospital Shanghai China

4. Radiology Department First Hospital of Jilin University Changchun Jilin China

5. State Key Laboratory of Experimental Hematology Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College Tianjin China

6. Hematology Department Second Hospital of Shanxi Medical University Taiyuan Shanxi China

7. Division of Hematology Mayo Clinic College of Medicine Rochester Minnesota USA

Funder

Department of Science and Technology of Jilin Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26774

Reference52 articles.

1. How I Treat High-risk Multiple Myeloma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China;Cancer Medicine;2024-09

2. The numerous facets of 1q21⁺ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review);Oncology Letters;2024-04-09

3. Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma;BMC Cancer;2024-04-02

4. PRUNE1 (located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion;British Journal of Haematology;2023-09-04

5. The prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma： a single‑center real world retrospective study of China;2023-08-02